From 2024 to 2025, the global continuous glucose monitoring (CGM) industry will exhibit a trend of technological innovation and strengthened compliance.
Under the "Healthy China" strategy, China's continuous glucose monitoring (CGM) industry is benefiting from both policy and market advantages.
Recently, Meiqui Medical, a domestic medical device company, has garnered significant attention with its dynamic glucose monitoring system due to its high cost-effectiveness and user-friendly design.